<DOC>
	<DOCNO>NCT00036712</DOCNO>
	<brief_summary>RATIONALE : Light-emitting diode ( LED ) therapy may able prevent mucositis mouth . PURPOSE : Randomized phase II trial determine effectiveness LED therapy prevent mucositis mouth child receive chemotherapy without radiation therapy donor bone marrow transplantation .</brief_summary>
	<brief_title>Light-Emitting Diode Therapy Preventing Mucositis Children Receiving Chemotherapy With Without Radiation Therapy Before Bone Marrow Transplantation</brief_title>
	<detailed_description>OBJECTIVES : - Compare incidence severity oral mucositis child undergo NASA-developed light-emitting diode ( LED ) therapy pre-transplantation myeloablative conditioning regimen ( chemotherapy without radiotherapy ) continue post-bone marrow transplantation ( BMT ) phase versus LED therapy post-BMT phase . OUTLINE : This randomize , double-blind , multicenter study . Patients stratify accord participate center cheek treat ( right v leave ) . Patients randomize 1 2 schedule light-emitting diode ( LED ) therapy . - Arm I : Patients undergo LED therapy 71 second daily begin day 1 myeloablative condition regimen comprise chemotherapy without radiotherapy continue 14 day bone marrow transplantation ( BMT ) . - Arm II : Patients undergo LED therapy arm I begin day BMT ( day 0 ) continue 14 day BMT . Photographs take right left buccal mucosa baseline every 3 day begin day 1 LED therapy . Pain xerostomia assess use Wong-Baker `` smiley-face '' pain scale baseline periodically 14 day BMT . Patients follow monthly 2 year . PROJECTED ACCRUAL : A total 80 patient ( 40 per arm ) accrue study within 2 year .</detailed_description>
	<mesh_term>Lymphoma</mesh_term>
	<mesh_term>Syndrome</mesh_term>
	<mesh_term>Leukemia</mesh_term>
	<mesh_term>Neoplasms</mesh_term>
	<mesh_term>Multiple Myeloma</mesh_term>
	<mesh_term>Neoplasms , Plasma Cell</mesh_term>
	<mesh_term>Myelodysplastic Syndromes</mesh_term>
	<mesh_term>Preleukemia</mesh_term>
	<mesh_term>Neuroblastoma</mesh_term>
	<mesh_term>Kidney Neoplasms</mesh_term>
	<mesh_term>Mucositis</mesh_term>
	<mesh_term>Myeloproliferative Disorders</mesh_term>
	<mesh_term>Myelodysplastic-Myeloproliferative Diseases</mesh_term>
	<mesh_term>Plasmacytoma</mesh_term>
	<criteria>DISEASE CHARACTERISTICS : Patients undergo myeloablative condition regimen comprise chemotherapy without radiotherapy prior first allogeneic bone marrow transplantation PATIENT CHARACTERISTICS : Age : 2 18 Performance status : Not specify Life expectancy : Not specify Hematopoietic : Not specify Hepatic : Not specify Renal : Not specify Pulmonary : No pulmonary dysfunction would increase significantly risk require intubation first 21 day transplantation Other : Not pregnant Negative pregnancy test Fertile patient must use effective contraception No photophobia Must emotional , cognitive , mental maturity sufficient tolerate lightemitting diode therapy application oral examination without combativeness PRIOR CONCURRENT THERAPY : Biologic therapy : See Disease Characteristics Chemotherapy : See Disease Characteristics Endocrine therapy : Not specify Radiotherapy : See Disease Characteristics Surgery : Not specify Other : No concurrent medication may cause epidermal ocular photosensitivity</criteria>
	<gender>All</gender>
	<minimum_age>2 Years</minimum_age>
	<maximum_age>18 Years</maximum_age>
	<verification_date>June 2009</verification_date>
	<keyword>recurrent childhood acute lymphoblastic leukemia</keyword>
	<keyword>refractory multiple myeloma</keyword>
	<keyword>recurrent childhood rhabdomyosarcoma</keyword>
	<keyword>disseminate neuroblastoma</keyword>
	<keyword>recurrent neuroblastoma</keyword>
	<keyword>recurrent Wilms tumor childhood kidney tumor</keyword>
	<keyword>recurrent childhood lymphoblastic lymphoma</keyword>
	<keyword>stage III chronic lymphocytic leukemia</keyword>
	<keyword>stage IV chronic lymphocytic leukemia</keyword>
	<keyword>recurrent childhood acute myeloid leukemia</keyword>
	<keyword>relapse chronic myelogenous leukemia</keyword>
	<keyword>refractory chronic lymphocytic leukemia</keyword>
	<keyword>chronic phase chronic myelogenous leukemia</keyword>
	<keyword>accelerated phase chronic myelogenous leukemia</keyword>
	<keyword>blastic phase chronic myelogenous leukemia</keyword>
	<keyword>primary myelofibrosis</keyword>
	<keyword>childhood acute promyelocytic leukemia ( M3 )</keyword>
	<keyword>refractory hairy cell leukemia</keyword>
	<keyword>oral complication</keyword>
	<keyword>recurrent/refractory childhood Hodgkin lymphoma</keyword>
	<keyword>de novo myelodysplastic syndrome</keyword>
	<keyword>previously treat myelodysplastic syndrome</keyword>
	<keyword>secondary myelodysplastic syndrome</keyword>
	<keyword>pain</keyword>
	<keyword>recurrent childhood small noncleaved cell lymphoma</keyword>
	<keyword>recurrent childhood large cell lymphoma</keyword>
	<keyword>previously treat childhood rhabdomyosarcoma</keyword>
	<keyword>childhood malignant ovarian germ cell tumor</keyword>
	<keyword>childhood chronic myelogenous leukemia</keyword>
	<keyword>atypical chronic myeloid leukemia , BCR-ABL1 negative</keyword>
	<keyword>myelodysplastic/myeloproliferative neoplasm , unclassifiable</keyword>
	<keyword>childhood myelodysplastic syndrome</keyword>
</DOC>